University of Oxford
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Private
- Established
- 1096-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.ox.ac.uk
Safety, Immunogenicity and Efficacy of R21 Matrix-M in 5-17 Month Old Children in Nanoro, Burkina Faso
Phase 1
Completed
- Conditions
- Malaria,Falciparum
- Interventions
- Biological: R21 adjuvanted with 25mcg Matrix-MBiological: Rabies VaccineBiological: R21 adjuvanted with 50mcg Matrix-M
- First Posted Date
- 2019-04-01
- Last Posted Date
- 2023-09-07
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 450
- Registration Number
- NCT03896724
- Locations
- 🇧🇫
Institut de Recherche en Sciences de la Sante - Clinical Research Unit of Nanoro (IRSS-URCN), Nanoro, Burkina Faso
Study to Compare Blood Levels of Ceftriaxone Given by Suppository or Injection.
Phase 1
Not yet recruiting
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-03-29
- Last Posted Date
- 2025-02-25
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 37
- Registration Number
- NCT03895567
- Locations
- 🇹🇭
Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand
Cardiovascular Function and Ribavirin Pharmacokinetics and Pharmacodynamics in Patients With Lassa Fever
- First Posted Date
- 2019-03-26
- Last Posted Date
- 2022-07-06
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 2
- Registration Number
- NCT03889106
- Locations
- 🇸🇱
Kenema Government Hospital, Kenema, Sierra Leone
Understanding How Salmonella Typhi Infects Humans (Bottlenecks)
Not Applicable
Completed
- Conditions
- Salmonella Typhi Infection
- Interventions
- Biological: Salmonella Typhi challenge
- First Posted Date
- 2019-03-26
- Last Posted Date
- 2022-02-09
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 11
- Registration Number
- NCT03889067
- Locations
- 🇬🇧
Centre for Clinical Vaccinology and Tropical Medicine (CCVTM), Oxford, Oxfordshire, United Kingdom
Neonatal Hyperbilirubinaemia in the Democratic Republic of Congo
Completed
- Conditions
- Neonatal Hyperbilirubinemia
- First Posted Date
- 2019-03-19
- Last Posted Date
- 2020-12-14
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 306
- Registration Number
- NCT03880591
- Locations
- 🇨🇩
Kinshasa Medical Oxford Research Unit, Kinsasa, Congo, The Democratic Republic of the
Effects of Acute Prucalopride Administration in Healthy Volunteers
Not Applicable
Completed
- Conditions
- Mood DisordersMental DisorderMolecular Mechanisms of Pharmacological ActionAntidepressive AgentsDepressionDepressive DisorderCognition
- Interventions
- Other: Placebo
- First Posted Date
- 2019-03-05
- Last Posted Date
- 2019-03-05
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 41
- Registration Number
- NCT03863366
- Locations
- 🇬🇧
University of Oxford, Oxford, United Kingdom
Oxford Haemodynamic Adaptation to Reduce Pulsatility Trial
Phase 2
Completed
- Conditions
- Small Vessel Cerebrovascular Disease
- Interventions
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2023-02-24
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 75
- Registration Number
- NCT03855332
- Locations
- 🇬🇧
University of Oxford, Oxford, Oxon, United Kingdom
Type 2 Diabetes: Risk Perceptions and Self-management Behaviour
Not Applicable
Completed
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Other: Personalized Risk Communication for People with Type 2 Diabetes
- First Posted Date
- 2019-02-15
- Last Posted Date
- 2019-02-15
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 40
- Registration Number
- NCT03840850
- Locations
- 🇬🇧
27 Beaumont Street Surgery Practice, Oxford, Oxfordshire, United Kingdom
VAccination in Early and ADvanced Prostate caNCEr
Phase 1
- Conditions
- Castration-resistant Prostate CancerIntermediate Risk Prostate Cancer
- Interventions
- Biological: ChAdOx1-MVA 5T4 vaccine
- First Posted Date
- 2019-01-24
- Last Posted Date
- 2020-12-01
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 23
- Registration Number
- NCT03815942
- Locations
- 🇬🇧
Cancer and Haematology Centre, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust, Oxford, United Kingdom
🇬🇧Department of Oncology, The Christie NHS Foundation Trust, Manchester, United Kingdom
OxPALM: Oxford Study on Probiotics and Low Mood
Not Applicable
- Conditions
- Cognitive ChangeMood
- Interventions
- Dietary Supplement: Bio-KultOther: Placebo
- First Posted Date
- 2019-01-11
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- University of Oxford
- Target Recruit Count
- 60
- Registration Number
- NCT03801655
- Locations
- 🇬🇧
Warneford Hospital, Oxford, Oxfordshire, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath